309 related articles for article (PubMed ID: 10832278)
1. [Neuroendocrine tumors of the lung].
Oliaro A; Donati G; Filosso PL; Ruffini E
Minerva Chir; 2000; 55(1-2):7-16. PubMed ID: 10832278
[TBL] [Abstract][Full Text] [Related]
2. Atypical bronchial carcinoids. Review of 46 patients.
Oliaro A; Filosso PL; Donati G; Ruffini E
J Cardiovasc Surg (Torino); 2000 Feb; 41(1):131-5. PubMed ID: 10836239
[TBL] [Abstract][Full Text] [Related]
3. Surgical treatment of neuroendocrine tumors of the lung.
Daddi N; Ferolla P; Urbani M; Semeraro A; Avenia N; Ribacchi R; Puma F; Daddi G
Eur J Cardiothorac Surg; 2004 Oct; 26(4):813-7. PubMed ID: 15450578
[TBL] [Abstract][Full Text] [Related]
4. Typical and atypical carcinoid tumours: analysis of the experience of the Spanish Multi-centric Study of Neuroendocrine Tumours of the Lung.
García-Yuste M; Matilla JM; Cueto A; Paniagua JM; Ramos G; Cañizares MA; Muguruza I;
Eur J Cardiothorac Surg; 2007 Feb; 31(2):192-7. PubMed ID: 17196822
[TBL] [Abstract][Full Text] [Related]
5. A clinicopathological study of peripheral, small-sized high-grade neuroendocrine tumours of the lung: differences between small-cell lung carcinoma and large-cell neuroendocrine carcinoma.
Isaka M; Nakagawa K; Ohde Y; Okumura T; Watanabe R; Ito I; Nakajima T; Kondo H
Eur J Cardiothorac Surg; 2012 Apr; 41(4):841-6. PubMed ID: 22219429
[TBL] [Abstract][Full Text] [Related]
6. Large cell neuroendocrine carcinoma: an aggressive form of non-small cell lung cancer.
Battafarano RJ; Fernandez FG; Ritter J; Meyers BF; Guthrie TJ; Cooper JD; Patterson GA
J Thorac Cardiovasc Surg; 2005 Jul; 130(1):166-72. PubMed ID: 15999058
[TBL] [Abstract][Full Text] [Related]
7. Alteration of the E-cadherin/beta-catenin cell adhesion system is common in pulmonary neuroendocrine tumors and is an independent predictor of lymph node metastasis in atypical carcinoids.
Pelosi G; Scarpa A; Puppa G; Veronesi G; Spaggiari L; Pasini F; Maisonneuve P; Iannucci A; Arrigoni G; Viale G
Cancer; 2005 Mar; 103(6):1154-64. PubMed ID: 15712207
[TBL] [Abstract][Full Text] [Related]
8. The impact of stage and cell type on the prognosis of pulmonary neuroendocrine tumors.
Lim E; Yap YK; De Stavola BL; Nicholson AG; Goldstraw P
J Thorac Cardiovasc Surg; 2005 Oct; 130(4):969-72. PubMed ID: 16214506
[TBL] [Abstract][Full Text] [Related]
9. Large cell neuroendocrine carcinoma of the lung: an aggressive disease potentially treatable with surgery.
Doddoli C; Barlesi F; Chetaille B; Garbe L; Thomas P; Giudicelli R; Fuentes P
Ann Thorac Surg; 2004 Apr; 77(4):1168-72. PubMed ID: 15063228
[TBL] [Abstract][Full Text] [Related]
10. Neuroendocrine neoplasms of the larynx: an overview.
Ferlito A; Silver CE; Bradford CR; Rinaldo A
Head Neck; 2009 Dec; 31(12):1634-46. PubMed ID: 19536850
[TBL] [Abstract][Full Text] [Related]
11. [Bronchopulmonary carcinoids: surgical therapy and prognosis].
Huwer H; Kalweit G; Krüger B; Straub U; Schäfers HJ
Pneumologie; 1996 Nov; 50(11):786-9. PubMed ID: 9082447
[TBL] [Abstract][Full Text] [Related]
12. [Pulmonary neuroendocrine tumors. The spectrum of histologic subtypes and current concept on diagnosis and treatment].
Langfort R; Rudziński P; Burakowska B
Pneumonol Alergol Pol; 2010; 78(1):33-46. PubMed ID: 20162517
[TBL] [Abstract][Full Text] [Related]
13. Head and neck large cell neuroendocrine carcinoma should be separated from atypical carcinoid on the basis of different clinical features, overall survival, and pathogenesis.
Kao HL; Chang WC; Li WY; Chia-Heng Li A; Fen-Yau Li A
Am J Surg Pathol; 2012 Feb; 36(2):185-92. PubMed ID: 22082601
[TBL] [Abstract][Full Text] [Related]
14. Radical cystectomy for primary neuroendocrine tumors of the bladder: the university of southern california experience.
Quek ML; Nichols PW; Yamzon J; Daneshmand S; Miranda G; Cai J; Groshen S; Stein JP; Skinner DG
J Urol; 2005 Jul; 174(1):93-6. PubMed ID: 15947585
[TBL] [Abstract][Full Text] [Related]
15. Carcinoid tumors of the lung: do atypical features require aggressive management?
Marty-Ané CH; Costes V; Pujol JL; Alauzen M; Baldet P; Mary H
Ann Thorac Surg; 1995 Jan; 59(1):78-83. PubMed ID: 7818364
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of MIB-1 in neuroendocrine tumours of the lung.
Böhm J; Koch S; Gais P; Jütting U; Präuer HW; Höfler H
J Pathol; 1996 Apr; 178(4):402-9. PubMed ID: 8691318
[TBL] [Abstract][Full Text] [Related]
17. Neuroendocrine neoplasms of the lung: a prognostic spectrum.
Asamura H; Kameya T; Matsuno Y; Noguchi M; Tada H; Ishikawa Y; Yokose T; Jiang SX; Inoue T; Nakagawa K; Tajima K; Nagai K
J Clin Oncol; 2006 Jan; 24(1):70-6. PubMed ID: 16382115
[TBL] [Abstract][Full Text] [Related]
18. [Histology does not accurately predict the clinical behaviour of bronchopulmonary carcinoids - results from an Icelandic population-based study].
Sigurdardottir JM; Isaksson HJ; Johannsson KB; Jonsson S; Gudbjartsson T
Laeknabladid; 2008 Feb; 94(2):125-30. PubMed ID: 18310777
[TBL] [Abstract][Full Text] [Related]
19. Pulmonary carcinoid and related tumours.
Hasleton PS; Bostanci G
Rocz Akad Med Bialymst; 1997; 42 Suppl 1():28-42. PubMed ID: 9337521
[TBL] [Abstract][Full Text] [Related]
20. Prognostic factors in neuroendocrine lung tumors: a Spanish Multicenter Study. Spanish Multicenter Study of Neuroendocrine Tumors of the Lung of the Spanish Society of Pneumonology and Thoracic Surgery (EMETNE-SEPAR).
García-Yuste M; Matilla JM; Alvarez-Gago T; Duque JL; Heras F; Cerezal LJ; Ramos G
Ann Thorac Surg; 2000 Jul; 70(1):258-63. PubMed ID: 10921719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]